Innoviva (INVA) Treasury Shares (2009 - 2024)
Innoviva posted quarterly Treasury Shares of $393.8 million for Q1 2024, little changed year-on-year from $393.8 million in Q2 2023, and little changed on a QoQ basis from $393.8 million in Q4 2023.
Innoviva (INVA) has 9 years of Treasury Shares data on file, last reported at $393.8 million in Q1 2024.
- For the quarter ending Q1 2024, Treasury Shares changed 0.0% year-over-year to $393.8 million; the trailing twelve-month figure through Mar 2024 stood at $393.8 million (changed 0.0% YoY), and the FY2023 full-year result was $393.8 million, changed 0.0% from the prior year.
- Treasury Shares for Q1 2024 stood at $393.8 million, roughly flat from $393.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $32.0 million in Q3 2021 and bottomed at -$32.0 million in Q2 2021.
- The 4-year median for Treasury Shares is $32.0 million (2021), against an average of $16.1 million.
- Peak annual rise in Treasury Shares reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- A 4-year view of Treasury Shares shows it stood at $393.8 million in 2021, then changed by 0.0% to $393.8 million in 2022, then changed by 0.0% to $393.8 million in 2023, then changed by 0.0% to $393.8 million in 2024.
- The last three Treasury Shares figures came in at $393.8 million (Q1 2024), $393.8 million (Q4 2023), and $393.8 million (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 393.83 Mn |
| Mar 31, 2024 | 634,000.00 |
| Mar 31, 2024 | 634,000.00 |
| Mar 31, 2024 | 393.83 Mn |
| Dec 31, 2023 | 32.01 Mn |
| Dec 31, 2023 | 393.83 Mn |
| Dec 31, 2023 | 393.83 Mn |
| Dec 31, 2023 | 32.01 Mn |
| Sep 30, 2023 | 393.83 Mn |
| Sep 30, 2023 | 393.83 Mn |
| Jun 30, 2023 | 32.01 Mn |
| Jun 30, 2023 | 393.83 Mn |
| Jun 30, 2023 | 393.83 Mn |
| Jun 30, 2023 | 32.01 Mn |
| Mar 31, 2023 | 393.83 Mn |
| Mar 31, 2023 | 393.83 Mn |
| Dec 31, 2022 | 32.01 Mn |
| Dec 31, 2022 | 393.83 Mn |
| Dec 31, 2022 | 393.83 Mn |
| Dec 31, 2022 | 32.01 Mn |
| Sep 30, 2022 | 393.83 Mn |
| Sep 30, 2022 | 32.01 Mn |
| Sep 30, 2022 | 32.01 Mn |
| Sep 30, 2022 | 393.83 Mn |
| Jun 30, 2022 | 32.01 Mn |
| Jun 30, 2022 | 32.01 Mn |
| Mar 31, 2022 | 32.01 Mn |
| Mar 31, 2022 | 32.01 Mn |
| Dec 31, 2021 | -32.01 Mn |
| Dec 31, 2021 | 393.83 Mn |
| Dec 31, 2021 | 393.83 Mn |
| Dec 31, 2021 | -32.01 Mn |
| Sep 30, 2021 | 32.01 Mn |
| Sep 30, 2021 | 32.01 Mn |
| Sep 30, 2021 | 393.83 Mn |
| Sep 30, 2021 | 393.83 Mn |
| Jun 30, 2021 | -32.01 Mn |
| Jun 30, 2021 | 393.83 Mn |
| Jun 30, 2021 | 393.83 Mn |
| Jun 30, 2021 | -32.01 Mn |
| Dec 31, 2018 | 77,000.00 |
| Dec 31, 2018 | 77,000.00 |
| Sep 30, 2018 | 3.26 Mn |
| Sep 30, 2018 | 150,000.00 |
| Sep 30, 2018 | 150,000.00 |
| Sep 30, 2018 | 3.26 Mn |
| Jun 30, 2018 | 3.26 Mn |
| Jun 30, 2018 | 3.26 Mn |
| Jun 30, 2018 | 150,000.00 |
| Jun 30, 2018 | 150,000.00 |
| Mar 31, 2018 | 150,000.00 |
| Mar 31, 2018 | 3.26 Mn |
| Mar 31, 2018 | 3.26 Mn |
| Mar 31, 2018 | 150,000.00 |
| Dec 31, 2017 | 3.26 Mn |
| Dec 31, 2017 | 3.26 Mn |
| Dec 31, 2017 | 1.45 Mn |
| Dec 31, 2017 | 1.45 Mn |
| Sep 30, 2017 | 150,000.00 |
| Sep 30, 2017 | 3.26 Mn |
| Sep 30, 2017 | 3.26 Mn |
| Sep 30, 2017 | 150,000.00 |
| Jun 30, 2017 | 3.26 Mn |
| Jun 30, 2017 | 150,000.00 |
| Jun 30, 2017 | 150,000.00 |
| Jun 30, 2017 | 3.26 Mn |
| Mar 31, 2017 | 150,000.00 |
| Mar 31, 2017 | 3.26 Mn |
| Mar 31, 2017 | 3.26 Mn |
| Mar 31, 2017 | 150,000.00 |
| Dec 31, 2016 | 3.26 Mn |
| Dec 31, 2016 | 1.13 Mn |
| Dec 31, 2016 | 1.13 Mn |
| Dec 31, 2016 | 3.26 Mn |
| Sep 30, 2016 | 150,000.00 |
| Sep 30, 2016 | 3.26 Mn |
| Sep 30, 2016 | 3.26 Mn |
| Sep 30, 2016 | 150,000.00 |
| Jun 30, 2016 | 3.26 Mn |
| Jun 30, 2016 | 3.26 Mn |
| Jun 30, 2016 | 63,135.00 |
| Jun 30, 2016 | 63,135.00 |
| Mar 31, 2016 | 63,000.00 |
| Mar 31, 2016 | 3.26 Mn |
| Mar 31, 2016 | 63,000.00 |
| Mar 31, 2016 | 3.26 Mn |
| Dec 31, 2015 | 2.68 Mn |
| Dec 31, 2015 | 2.68 Mn |
| Dec 31, 2015 | 3.26 Mn |
| Dec 31, 2015 | 3.26 Mn |
| Sep 30, 2015 | 63,000.00 |
| Sep 30, 2015 | 3.26 Mn |
| Sep 30, 2015 | 3.26 Mn |
| Sep 30, 2015 | 63,000.00 |
| Jun 30, 2015 | 63,000.00 |
| Jun 30, 2015 | 63,000.00 |
| Jun 30, 2015 | 3.26 Mn |
| Jun 30, 2015 | 3.26 Mn |
| Mar 31, 2015 | 3.26 Mn |
| Mar 31, 2015 | 3.26 Mn |
| Mar 31, 2015 | 150,000.00 |
| Mar 31, 2015 | 150,000.00 |
| Dec 31, 2014 | 150,000.00 |
| Dec 31, 2014 | 3.26 Mn |
| Dec 31, 2014 | 3.26 Mn |
| Dec 31, 2014 | 150,000.00 |
| Sep 30, 2014 | 63,000.00 |
| Sep 30, 2014 | 3.26 Mn |
| Sep 30, 2014 | 3.26 Mn |
| Sep 30, 2014 | 63,000.00 |
| Dec 31, 2013 | 1.12 Mn |
| Dec 31, 2013 | 1.12 Mn |
| Dec 31, 2012 | 1.24 Mn |
| Dec 31, 2012 | 1.24 Mn |
| Dec 31, 2011 | 1.54 Mn |
| Dec 31, 2011 | 1.54 Mn |
| Dec 31, 2010 | 1.90 Mn |
| Dec 31, 2010 | 1.90 Mn |
| Dec 31, 2009 | 2.04 Mn |
| Dec 31, 2009 | 2.04 Mn |